| PRESENTED BY:
• National Institute of Child Health and Human Development,
NIH
• Office of Rare Diseases, NIH
• National Cancer Institute, NIH
• National Institutes of Neurological Disorders and Stroke, NIH
• National Human Genome Research Institute, NIH
ADDITIONAL FINANCIAL SUPPORT PROVIDED BY:
• Molecular Insight Pharmaceuticals • GE Healthcare • Novartis, Germany
• Endocrine Technologies, Germany
• German Society of Endocrinology
• Novartis Oncology
• Daiichi Radioisotope Labs., Ltd., Japan
CHROMAFFIN
CELL MEETING
PRESSOR WEBSITE
|